S E Nennig1, J R Schank1. 1. Department of Physiology and Pharmacology, University of Georgia, 501 D.W. Brooks Drive, Athens, GA 30602, USA.
Abstract
AIMS: Nuclear factor kappa light chain enhancer of activated B cells (NFkB) is a ubiquitous transcription factor well known for its role in the innate immune response. As such, NFkB is a transcriptional activator of inflammatory mediators such as cytokines. It has recently been demonstrated that alcohol and other drugs of abuse can induce NFkB activity and cytokine expression in the brain. A number of reviews have been published highlighting this effect of alcohol, and have linked increased NFkB function to neuroimmune-stimulated toxicity. However, in this review we focus on the potentially non-immune functions of NFkB as possible links between NFkB and addiction. METHODS: An extensive review of the literature via Pubmed searches was used to assess the current state of the field. RESULTS: NFkB can induce the expression of a diverse set of gene targets besides inflammatory mediators, some of which are involved in addictive processes, such as opioid receptors and neuropeptides. NFkB mediates complex behaviors including learning and memory, stress responses, anhedonia and drug reward, processes that may lie outside the role of NFkB in the classic neuroimmune response. CONCLUSIONS: Future studies should focus on these non-immune functions of NFkB signaling and their association with addiction-related processes.
AIMS: Nuclear factor kappa light chain enhancer of activated B cells (NFkB) is a ubiquitous transcription factor well known for its role in the innate immune response. As such, NFkB is a transcriptional activator of inflammatory mediators such as cytokines. It has recently been demonstrated that alcohol and other drugs of abuse can induce NFkB activity and cytokine expression in the brain. A number of reviews have been published highlighting this effect of alcohol, and have linked increased NFkB function to neuroimmune-stimulated toxicity. However, in this review we focus on the potentially non-immune functions of NFkB as possible links between NFkB and addiction. METHODS: An extensive review of the literature via Pubmed searches was used to assess the current state of the field. RESULTS: NFkB can induce the expression of a diverse set of gene targets besides inflammatory mediators, some of which are involved in addictive processes, such as opioid receptors and neuropeptides. NFkB mediates complex behaviors including learning and memory, stress responses, anhedonia and drug reward, processes that may lie outside the role of NFkB in the classic neuroimmune response. CONCLUSIONS: Future studies should focus on these non-immune functions of NFkB signaling and their association with addiction-related processes.
Authors: H Kono; M D Wheeler; I Rusyn; M Lin; V Seabra; C A Rivera; B U Bradford; D T Forman; R G Thurman Journal: Am J Physiol Gastrointest Liver Physiol Date: 2000-04 Impact factor: 4.052
Authors: Stephen D Mague; Andrea M Pliakas; Mark S Todtenkopf; Hilarie C Tomasiewicz; Yan Zhang; William C Stevens; Robert M Jones; Philip S Portoghese; William A Carlezon Journal: J Pharmacol Exp Ther Date: 2003-04 Impact factor: 4.030
Authors: Katia P Karalis; Maria Venihaki; Jie Zhao; Lilian E van Vlerken; Christina Chandras Journal: J Biol Chem Date: 2004-01-06 Impact factor: 5.157
Authors: Jennifer M Loftis; Juno Valerio; Jonathan Taylor; Elaine Huang; Rebekah Hudson; Patricia Taylor-Young; Michael Chang; Samuel B Ho; Eric Dieperink; Juan Luis Miranda; Peter Hauser Journal: Alcohol Clin Exp Res Date: 2018-06-28 Impact factor: 3.455
Authors: S E Nennig; H D Fulenwider; S H Chimberoff; B M Smith; J E Eskew; M K Sequeira; C Karlsson; C Liang; J F Chen; M Heilig; J R Schank Journal: Neuropsychopharmacology Date: 2017-09-13 Impact factor: 7.853
Authors: David W Volk; Annie E Moroco; Kaitlyn M Roman; Jessica R Edelson; David A Lewis Journal: Biol Psychiatry Date: 2018-06-28 Impact factor: 13.382
Authors: Sadie E Nennig; Hannah D Fulenwider; Jacob E Eskew; Kimberly E Whiting; Mallory R Cotton; Gabrielle E McGinty; Matthew G Solomon; Jesse R Schank Journal: Alcohol Clin Exp Res Date: 2020-02-03 Impact factor: 3.455